11 Jan 2019 Research

Myelofibrosis: Finding new ways to treat patients

Myelofibrosis is a fatal bone marrow cancer. The disease is caused by excessive secretion of factors by cancerous platelet-producing cells called megakaryocytes. These secretions cause the replacement of normal bone marrow tissue with fibrous scar tissue.

Dr Chen’s team can successfully recreate this pathological bone marrow environment in the laboratory, and their preliminary research data shows that reduced levels of a protein complex called FANCcore leads to more myelofibrosis.

Dr Chen’s team hypothesise that loss of the protein complex FANCcore increases the growth of myelfibrosis by altering megakaryocytes. Dr Chen uses both human tissue cultures and mouse models to examine the cellular and molecular changes to megakaryocytes following the absence of the FANCcore complex and to understand how these changes cause myelofibrosis.

The team hopes that by focusing on the role of FANCcore in megakaryocyte biology, they can reveal new ways to treat myelofibrosis.

Related posts

New book ‘Bronty’s Battle Cry’ supports Leukaemia UK

30 June 2023

New book ‘Bronty’s Battle Cry’ supports Leukaemia UK

‘Bronty’s Battle Cry,’ an inspiring new picture book written by award-winning children’s author and young person’s counsellor, Hannah Peckham, has recently launched and Leukaemia UK are delighted that some of…

Leukaemia charities unite in Blood Cancer Awareness Month to improve diagnosis and the chances of survival

20 September 2021

Leukaemia charities unite in Blood Cancer Awareness Month to improve diagnosis and the chances of survival

Leading UK leukaemia charities Leukaemia Care and Leukaemia UK have announced a new collaboration to increase awareness of the signs and symptoms of leukaemia and drive improvements in the diagnosis of the disease. The campaign, Spot Leukaemia, is running throughout September – Blood Cancer Awareness Month.

Our life-saving work must continue

4 August 2020

Our life-saving work must continue

Leukaemia and other blood cancers don’t stop for coronavirus (COVID-19) and our vital research and care must continue

New analysis reveals the stark disparities in cancer rates between ethnic groups

3 February 2022

New analysis reveals the stark disparities in cancer rates between ethnic groups

The Cancer Research UK study demonstrates the importance of understanding the differences and inequalities in cancer and to highlight where improvements in survival, treatment and care can be made.